Skip to main content
SpringerLink
Log in

Vismodegib associated with hepatotoxicity

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Edwards BJ, et al. Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project. Drugs in R and D : 6 Jan 2017. Available from: URL: http://doi.org/10.1007/s40268-016-0168-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vismodegib associated with hepatotoxicity. Reactions Weekly 1635, 13 (2017). https://doi.org/10.1007/s40278-017-25262-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-25262-4

Search

Navigation